Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia

Next generation sequencing in diagnosis and MRD assessment of AML

(2019) Ross L. Levine et al.   HAEMATOLOGICA

Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000

(2018) Hagop M. Kantarjian et al.   CANCER

Serum Albumin or Body Mass Index: which prognostic factor for survival in patients with Acute Myeloblastic Leukaemia?

(2018) Lauriane Filliatre-Clement et al.   HEMATOLOGICAL ONCOLOGY

Acute myeloid leukemia: 2019 update on risk-stratification and management

(2018) Elihu H. Estey   AMERICAN JOURNAL OF HEMATOLOGY

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

(2018) Courtney D. DiNardo et al.   BLOOD

Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3 -internal tandem duplication genotypes

(2018) Prajwal C. Boddu et al.   CANCER

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use

(2018) Ulrike Bacher et al.   Blood Cancer Journal

Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience

(2017) Mariana Tereza de Lira Benicio et al.   LEUKEMIA RESEARCH

Precision oncology for acute myeloid leukemia using a knowledge bank approach

(2017) Moritz Gerstung et al.   NATURE GENETICS

Determining the optimal number and location of cutoff points with application to data of cervical cancer

(2017) Chung Chang et al.   PLoS One

Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

(2017) Mohamed L. Sorror et al.   JAMA Oncology

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

(2016) Hartmut Döhner et al.   BLOOD

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Assessment of Minimal Residual Disease in Standard-Risk AML

(2016) Adam Ivey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic Classification and Prognosis in Acute Myeloid Leukemia

(2016) Elli Papaemmanuil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum Albumin Levels and Economic Status in Japanese Older Adults

(2016) Asami Ota et al.   PLoS One

Hematopoietic stem cell transplantation for patients with AML in first complete remission

(2015) J. J. Cornelissen et al.   BLOOD

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

(2015) Antonio Palumbo et al.   JOURNAL OF CLINICAL ONCOLOGY

Acute Myeloid Leukemia

(2015) Hartmut Döhner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Albumin and its application in drug delivery

(2014) Darrell Sleep   Expert Opinion on Drug Delivery

Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia

(2014) Friederike Pastore et al.   JOURNAL OF CLINICAL ONCOLOGY

Integrative prognostic risk score in acute myeloid leukemia with normal karyotype

(2011) F. Damm et al.   BLOOD

Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment

(2011) Roland B. Walter et al.   JOURNAL OF CLINICAL ONCOLOGY

Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature

(2011) Digant Gupta et al.   Nutrition Journal

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

(2010) D. Grimwade et al.   BLOOD

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

(2009) B. J. Wouters et al.   BLOOD

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes

(2008) Apostolia Maria Tsimberidou et al.   CANCER